News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Industry Trends

>
  • IR Licensing and Partnerships

Latest News

Regeneron Acquires 23andMe for $256 Million in Bankruptcy Deal
Regeneron Acquires 23andMe for $256 Million in Bankruptcy Deal
By Don Tracy, Associate Editor

May 19th 2025

Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations.

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
By Don Tracy, Associate Editor

May 16th 2025

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in its strategic plans amid recent market challenges.

Earned Media and ASCO: Provide Context Beyond the Data
Earned Media and ASCO: Provide Context Beyond the Data
By Michael Christel

May 13th 2025

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.

GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
By Don Tracy, Associate Editor

May 13th 2025

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society of Health-System Pharmacists, who warns of tariff-driven supply chain threats and continued growth in clinic drug costs.

Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
By Don Tracy, Associate Editor

April 28th 2025

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on high-impact innovations.

Video Interviews
Podcasts

More News


Pharm Exec's 2025 State of the Industry Survey

Pharm Exec's 2025 State of the Industry Survey

Michael Christel
May 16th 2025

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.


Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation

Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation

Don Tracy, Associate Editor
April 22nd 2025

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics production, gene therapy capabilities, and next generation R&D centers.


Improving Your Earned Media Strategy: Tips and Insights

Improving Your Earned Media Strategy: Tips and Insights

Michael Christel
April 16th 2025

Introducing a new series highlighting ways pharma companies can up their game in winning earned media—and ultimately deliver greater impact and value from their messaging.


Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

Don Tracy, Associate Editor
April 11th 2025

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.


Mehtap Saydam Aydemir

Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic Roadmap

Mehtap Saydam Aydemir
March 17th 2025

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.


Elaina Shekhter, EPAM Chief Marketing & Strategy Officer.

Preparing for the C-Suite

Michael Wong
March 13th 2025

A Harvard Business School Healthcare Alumni Association Q&A with Elaina Shekhter, EPAM’s Chief Marketing & Strategy Officer.


Scott Snyder

Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder

Mike Hollan
March 12th 2025

EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.


Heather Hunt

Healthcare’s Visual Future: Shaping Trust Through Design

Heather Hunt
March 6th 2025

The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their audiences.


2025 Pipeline Report: The Edge of Greatness?

2025 Pipeline Report: The Edge of Greatness?

Mike Straus
February 17th 2025

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five expanding therapeutic areas.


The Shifting Pharmacy Landscape in 2025

The Shifting Pharmacy Landscape in 2025

Josh Canavan, PharmD
February 13th 2025

Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.


Biopharma Business Check: Financing Review and Outlook

Biopharma Business Check: Financing Review and Outlook

Peter Young
February 13th 2025

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and biotech ahead.


Slideshow: PwC Report Identifies Top Trends in Pharma

Slideshow: PwC Report Identifies Top Trends in Pharma

Don Tracy, Associate Editor
February 12th 2025

PwC report identifies transformative trends impacting the pharma market this year and into the future.


Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Adam Zhang Yu
January 27th 2025

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.


Subin Baral

The Present and Future of M&A: Q&A with Subin Baral

Mike Hollan
January 20th 2025

The EY executive discusses trends in this sector and what he expects to see in the coming year.


Pete Lyons

The Impact of Digital Transformation in 2025: Q&A with Pete Lyons

Mike Hollan
January 8th 2025

Deloitte’s US life sciences sector leader discusses the trends he believes will have the most impact in 2025.


FDA Updates Guidelines on Compounding Tirzepatide Injections as GLP-1 Shortage Ends

FDA Updates Guidelines on Compounding Tirzepatide Injections as GLP-1 Shortage Ends

Don Tracy, Associate Editor
December 19th 2024

Amid the end of a national GLP-1 shortage, the FDA will now require all compounding, distributing, or dispensing of compounded tirzepatide injections to end within 90 days.


Seeking More Value, Less Cost

Seeking More Value, Less Cost

Michael Christel
December 17th 2024

The biosimilars market in the US is on the rise, but barriers to greater adoption remain.


Dealmaking Dormant No More

Dealmaking Dormant No More

Mike Hollan
December 17th 2024

Unleashed demand over the past year characterizes the M&A picture in pharma.


A Rocky Road for Regulation

A Rocky Road for Regulation

Mike Hollan
December 16th 2024

With the Inflation Reduction Act now in flux, how will the government and industry respond?


DTC's New Era of Engagement

DTC's New Era of Engagement

Don Tracy, Associate Editor
December 16th 2024

How alternative direct-to-consumer models are changing the landscape for patient access.


Holding On Tight to AI Wave

Holding On Tight to AI Wave

Mike Hollan
December 16th 2024

The swell of AI-powered digital platforms puts future decision-making under the spotlight.


The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.


Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.


Why Healthcare Costs are Surging—And  What to Do About it

Why Healthcare Costs are Surging—And What to Do About it

Thom Bales ;Philip Sclafani
December 12th 2024

Identifying the inflators and deflators, and the role all stakeholders play.


Navigating the Current Landscape for Pharma Leaders

Navigating the Current Landscape for Pharma Leaders

Mike Hollan
November 13th 2024

Decisions and strategies related to remote work, AI, and DE&I are especially evolving.


Mark Mikhael

The State of Compounding: Q&A with Olympia Pharmaceutical’s Mark Mikhael

Mike Hollan
October 28th 2024

The CEO discusses the current state of compounding pharmacies and how it built to this point.


Report: Radiopharmaceutical Market Expected to Reach $26.51 Billion by 2031

Report: Radiopharmaceutical Market Expected to Reach $26.51 Billion by 2031

Don Tracy, Associate Editor
October 25th 2024

Growth is expected due to increased instances of chronic diseases such as cancer and Alzheimer disease.


Are You Up to Date With the Latest FDA Guidance?

Are You Up to Date With the Latest FDA Guidance?

Pharmaceutical Press
October 8th 2024

Webinar Date/Time: Tue, Nov 19, 2024 11:00 AM EST


Claus Zieler

The Impact of Technology on Commercialization: Q&A with Claus Zieler

Mike Hollan
October 1st 2024

The Astellas chief commercial officer discusses the impact that the increase in global and local connectivity has had on commercialization, among other trends.


 Transform Real-World Evidence (RWE) Insights with Innovative Data Solutions

Transform Real-World Evidence (RWE) Insights with Innovative Data Solutions

NTT Data
September 24th 2024

Webinar Date/Time: Wed, Oct 16, 2024 2:00 PM EDT

12345678
...
19>
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.